Search research articles
Contact Us
Filters
Showing results (131-140 of 162) with videos related to
Page
of 17
Sort By:
Plos One
|
July 7, 2015
The Histone Methyltransferase Inhibitor A-366 Uncovers a Role for G9a/GLP in the Epigenetics of Leukemia
William N Pappano, Jun Guo, Yupeng He, et al.
Plos One
|
November 9, 2023
Seroepidemiological investigation of Crimean Congo hemorrhagic fever virus in livestock in Uganda, 2017
Luke Nyakarahuka, Jackson Kyondo, Carson Telford, et al.
Molecular Cancer Therapeutics
|
October 15, 2008
ABT-263 and rapamycin act cooperatively to kill lymphoma cells in vitro and in vivo
Scott Ackler, Yu Xiao, Michael J Mitten, et al.
Nature Ecology & Evolution
|
January 3, 2018
Evolutionary determinants of genome-wide nucleotide composition
Hongan Long, Way Sung, Sibel Kucukyildirim, et al.
ACS Medicinal Chemistry Letters
|
January 16, 2015
Pyrimidine-based tricyclic molecules as potent and orally efficacious inhibitors of wee1 kinase
Yunsong Tong, Maricel Torrent, Alan S Florjancic, et al.
Molecular Cancer Research : MCR
|
October 15, 2009
Acquired resistance to combination treatment with temozolomide and ABT-888 is mediated by both base excision repair and homologous recombination DNA repair pathways
Xuesong Liu, Edward K Han, Mark Anderson, et al.
The Journal of Clinical Investigation
|
November 21, 2023
Thrombotic microangiopathy following systemic AAV administration is dependent on anti-capsid antibodies
Stephanie M Salabarria, Manuela Corti, Kirsten E Coleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2008
Activity of the Bcl-2 family inhibitor ABT-263 in a panel of small cell lung cancer xenograft models
Alex R Shoemaker, Michael J Mitten, Jessica Adickes, et al.
Cancer Research
|
May 3, 2008
ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor
Christin Tse, Alexander R Shoemaker, Jessica Adickes, et al.
Journal of Medical Virology
|
October 7, 2024
A public, cross-reactive glycoprotein epitope confounds Ebola virus serology
Markus H Kainulainen, Jessica R Harmon, Elif Karaaslan, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 162) with videos related to
Sort By:
Page
of 17
Plos One
|
July 7, 2015
The Histone Methyltransferase Inhibitor A-366 Uncovers a Role for G9a/GLP in the Epigenetics of Leukemia
William N Pappano, Jun Guo, Yupeng He, et al.
Plos One
|
November 9, 2023
Seroepidemiological investigation of Crimean Congo hemorrhagic fever virus in livestock in Uganda, 2017
Luke Nyakarahuka, Jackson Kyondo, Carson Telford, et al.
Molecular Cancer Therapeutics
|
October 15, 2008
ABT-263 and rapamycin act cooperatively to kill lymphoma cells in vitro and in vivo
Scott Ackler, Yu Xiao, Michael J Mitten, et al.
Nature Ecology & Evolution
|
January 3, 2018
Evolutionary determinants of genome-wide nucleotide composition
Hongan Long, Way Sung, Sibel Kucukyildirim, et al.
ACS Medicinal Chemistry Letters
|
January 16, 2015
Pyrimidine-based tricyclic molecules as potent and orally efficacious inhibitors of wee1 kinase
Yunsong Tong, Maricel Torrent, Alan S Florjancic, et al.
Molecular Cancer Research : MCR
|
October 15, 2009
Acquired resistance to combination treatment with temozolomide and ABT-888 is mediated by both base excision repair and homologous recombination DNA repair pathways
Xuesong Liu, Edward K Han, Mark Anderson, et al.
The Journal of Clinical Investigation
|
November 21, 2023
Thrombotic microangiopathy following systemic AAV administration is dependent on anti-capsid antibodies
Stephanie M Salabarria, Manuela Corti, Kirsten E Coleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2008
Activity of the Bcl-2 family inhibitor ABT-263 in a panel of small cell lung cancer xenograft models
Alex R Shoemaker, Michael J Mitten, Jessica Adickes, et al.
Cancer Research
|
May 3, 2008
ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor
Christin Tse, Alexander R Shoemaker, Jessica Adickes, et al.
Journal of Medical Virology
|
October 7, 2024
A public, cross-reactive glycoprotein epitope confounds Ebola virus serology
Markus H Kainulainen, Jessica R Harmon, Elif Karaaslan, et al.
Page
of 17